25-hydroxyvitamin D concentrations in patients with optic neuritis as a clinically isolated syndrome and healthy controls

International Journal of Preventive Medicine

Volumn 3, Issue 5, 2012, Pages 313-317

  Etemadifar, Masoud ^a   Abtahi, Seyed Hossein ^a,b   Razmjoo, Hassan ^a,b   Abtahi, Mohammad Ali ^a,b   Dehghani, Alireza ^a,b   Salari, Mehri ^a   Maghzi, Amir Hadi ^a,c   Akbari, Mojtaba ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

25 hydroxyvitamin D; Iran; Isfahan; Multiple sclerosis; Optic neuritis; Prevention; Risk factor; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OPTIC NEURITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84862026222     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Milo R, Kahana E. Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmun Rev 2010;9: A387-A394.
2. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010;9:727-739.
3. Ascherio A, Munger K. Epidemiology of multiple sclerosis: From risk factors to prevention. Semin Neurol 2008;28:17-28.
4. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8.
5. Pierrot-Deseilligny C, Souberbielle JC. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 2010;133:1869-188.
6. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599-612.
7. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005;11:266-71.
8. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-308.
9. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002;360:1953-1962.
10. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-137.
11. Hickey L, Gordon CM. Vitamin D defciency: New perspectives on an old disease. Curr Opin Endocrinol Diabetes 2004;11:18-25.
12. Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M. Prevalence of Vitamin D Defciency in Isfahani High School Students in 2004. Horm Res 2005;64:144-158.
13. Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011;17:1022-1037.
14. Detels R, Visscher BR, Haile RW, Malmgren RM, Dudley JP, Coulson AH. Multiple sclerosis and age at migration. Am J Epidemiol 1978;108:386-393.
15. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-2838.
16. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, et al. Vitamin D status is associated with relapse rate in pediatric-onset MS. Ann Neurol 2010;67:618-624.
17. Prentice A. Vitamin D Defciency: A global perspective. Nutr Rev 2008;66: S153-S164.
18. Holick MF, Chen TC. VitaminD defciency: A worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-1086S.